MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com
Equities researchers at StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital assumed coverage on shares of MediciNova in a research report on Monday, December 2nd. They set a “buy” rating […]
Equities researchers at StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital assumed coverage on shares of MediciNova in a research report on Monday, December 2nd. They set a “buy” rating […]
